Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...

Accurate information and leadership buy-in are essential. The researchers noted three types of resistance that are common are denying, defending and distancing. One of the strategies suggested by ...

Clinging to how things have always been done can significantly hinder a healthcare company’s growth. As new products and services emerge and evolve, embracing innovation is critical to keeping up with ...

I used to think resistance was something to overcome. Fight through. Power past. For most of my career leading digital transformations, I treated pushback like a wall to break down rather than a door ...

Panelists discuss how overcoming resistance to EGFR TKIs requires next-generation inhibitors and more individualized treatment strategies. Panelists discuss how resistance to EGFR tyrosine kinase ...

Resistance—the pushback we feel when facing change—isn’t a flaw; it’s data. It signals unmet needs, unprocessed fears, or a lack of clarity. Why do we hesitate, avoid, or resist what’s ahead? With ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) ...

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.

When company leaders introduce AI to their workforces, they often face employee skepticism. Colgate-Palmolive and Rent a Mac use employee feedback and data to address AI pushback. This article is part ...

Resistance is a common challenge in caregiving, experienced by both caregivers and care recipients. It often reflects a desire to maintain control and cling to the familiar, especially during times of ...